Loading clinical trials...
Loading clinical trials...
The investigators want to investigate if a continuous heart rate monitoring with a wrist worn fitnesstracker can be useful in the treatment and surveillance of patients suffering from Graves' disease.The aim of our research project is two-fold: First, to evaluate the use of continuous heart rate monitoring as a potential substitute for hormone measurements during treatment of hyperthyroidism. Second, to use continuous heart rate monitoring as a tool for early detection of relapse after discontinuation of antithyroid drugs.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
University Hospital Basel
Basel, Switzerland
Start Date
June 8, 2021
Primary Completion Date
March 21, 2023
Completion Date
October 30, 2023
Last Updated
October 31, 2023
35
ACTUAL participants
Continuous heart rate monitoring
DIAGNOSTIC_TEST
Lead Sponsor
University Hospital, Basel, Switzerland
NCT04856488
NCT03517579
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07164079